Multisite Study of Women Living With HIV's Perceived Barriers to, and Interest in, Long-Acting Injectable Antiretroviral Therapy
2020; Lippincott Williams & Wilkins; Volume: 84; Issue: 3 Linguagem: Inglês
10.1097/qai.0000000000002337
ISSN1944-7884
AutoresMorgan M. Philbin, Carrigan Parish, Elizabeth N. Kinnard, Sarah E. Reed, Deanna Kerrigan, María L. Alcaide, Mardge H. Cohen, Oluwakemi Sosanya, Anandi N. Sheth, Adaora A. Adimora, Jennifer Cocohoba, Lakshmi Goparaju, Elizabeth T. Golub, Margaret A. Fischl, Lisa R. Metsch,
Tópico(s)LGBTQ Health, Identity, and Policy
ResumoAdherence to antiretroviral therapy (ART) is imperative for viral suppression and reducing HIV transmission, but many people living with HIV report difficultly sustaining long-term adherence. Long-acting injectable (LAI) ART has the potential to transform HIV treatment and prevention. However, little LAI ART-related behavioral research has occurred among women, particularly outside of clinical trials.
Referência(s)